Related Experiment Videos
Leucine zipper-mediated dimerization is essential for the PTC1 oncogenic activity
1Department of Physiology and the Department of Internal Medicine, Ohio State University, Columbus, Ohio 43210, USA.
The Journal of Biological Chemistry
|April 4, 1997
Summary
The PTC1 oncogene dimerizes in vivo via a leucine zipper, which is crucial for its transforming activity in papillary thyroid cancer. This dimerization is a potential target for cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The PTC1 chimeric oncogene, found in papillary thyroid carcinoma, results from RET proto-oncogene and H4 gene fusion.
- Previous studies showed H4's leucine zipper mediates PTC1 oncoprotein oligomerization in vitro.
Purpose of the Study:
- To investigate the in vivo dimerization of the PTC1 oncoprotein.
- To determine the role of the H4 leucine zipper in PTC1 dimerization and transforming activity.
- To explore the therapeutic potential of targeting PTC1 dimerization.
Main Methods:
- In vivo dimerization assays to confirm PTC1 oncoprotein dimer formation.
- Mutational analysis of the H4 leucine zipper to assess its role in dimerization.
- Cell transformation assays using PTC1 mutants to evaluate functional consequences.
Main Results:
- The PTC1 oncoprotein forms dimers in vivo, mediated by the H4 leucine zipper.
- Leucine zipper-mediated dimerization is essential for PTC1-induced tyrosine hyperphosphorylation and cell transformation.
- Introduction of a loss-of-function PTC1 mutant suppressed transforming activity by forming inactive heterodimers.
Conclusions:
- Constitutive dimerization of the PTC1 oncoprotein is critical for its transforming activity.
- Leucine zipper-mediated dimerization is a key mechanism for activating receptor tyrosine kinase oncogenes.
- Targeting PTC1 dimerization may offer a therapeutic strategy for papillary thyroid carcinoma.